A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

May 4, 2016

Primary Completion Date

September 9, 2019

Study Completion Date

February 28, 2027

Conditions
Parkinson's Disease
Interventions
DRUG

ND0612

ND0612, a solution of levodopa/carbidopa (LD/CD) delivered continuously subcutaneously (SC) via an infusion pump system

Trial Locations (57)

1307

Universitaetsklinikum Carl Gustav Carus an der Technischen Universitaet Dresden, Dresden

6020

Medical University Innsbruck, Innsbruck

13385

Hopital de la Timone, Marseille

13616

Centre Hospitalier d'Aix, Aix-en-Provence

14547

Kliniken Beelitz GmbH, Beelitz-Heilstätten

21201

University of Maryland, Neurology, Baltimore

23226

Synergy Trials, Richmond

27574

Klinikum-Bremerhaven Reinkenheide, Bremerhaven

28006

Hospital Universitario de la Princesa, Madrid

30126

IRCCS Hospital San Camillo Venice, Venice

32209

University of Florida Health at Jacksonville, Jacksonville

33009

MD Clinical, Hallandale

33021

Infinity Clinical Research, LLC, Hollywood

33351

Infinity Clinical Research, LLC, Sunrise

33613

USF Health Parkinson's Disease and Movement Disorders, Tampa

33980

Parkinsons Disease Treatment Center of Southwest Florida, Port Charlotte

44791

St. Josefs Hospital, Bochum

45267

University of Cincinnati, Cincinnati

48334

QUEST Research Institute, Farmington Hills

49100

Rabin Medical Center, Petah Tikva

50309

Unity Point Health, Des Moines

56126

AOU Pisa, Pisa

56520

Chaim Sheba Medical Center, Ramat Gan

59037

Hopital Roger Salengro, Lille

60611

Northwestern University, Chicago

63003

Hôpital Gabriel Montpied, Clermont-Ferrand

64239

Sourasky Medical Center, Tel Aviv

66100

University Foundation, Chieti

69677

Hopital Neurologique Pierre Wertheimer, Bron

74136

The Movement Disorder Clinic of Oklahoma, Tulsa

80045

University of Colorado Denver, Aurora

80054

CHU d'Amiens, Hopital Sud, Amiens

83527

Klinik Haag, Haag in Oberbayern

85004

Xenoscience, Phoenix

86021

CHU de Poitiers, Poitiers

89081

Universitaets-und Rehabilitationskliniken Ulm, Ulm

91120

Hadassah Medical Center, Ein-Kerem Campus, Jerusalem

93710

Neuro Pain Medical Center, Fresno

7830604

Barzilai MC, Ashkelon

72205-6421

Clinical Trials Inc., Little Rock

92708-5153

The Parkinsons and Movement Disorder Institute, Fountain Valley

80113-2776

Rocky Mountain Movement Disorders Center, Englewood

33486-2359

Parkinson's Disease and Movement Disorder Center of Boca Raton, Boca Raton

32751-4723

Neurology Associates, PA, Maitland

33713-8844

Suncoast Neuroscience Associates, St. Petersburg

48322-3013

Henry Ford Hospital, West Bloomfield

08873-3448

Pyramid Clinical Research, Somerset

23456-0168

Sentara Neuroscience Institute, Virginia Beach

99202-1461

Premier Research, Spokane

565 01

NEUROHK, s.r.o., Choceň

100 00

Clintrial s.r.o., Prague

516 01

Vestra Clinics, s.r.o., Rychnov nad Kněžnou

00163

IRCCS San Raffaele Pisana, Rome

30-363

Centrum Medyczne PLEJADY, Krakow

31-505

Krakowska Akademia Neurologii Sp. z o.o., Krakow

20-016

Indywidualna Praktyka Lekarska prof. dr hab, Lublin

08036

Hospital Clinic de Barcelona, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NeuroDerm Ltd.

INDUSTRY